---
title: "SANDERS CHARLES A — Ownership Dossier"
canonical: https://whiteintel.dev/entity/b4677ca1-d91c-5fc5-ba5d-40a91e323092
json: https://whiteintel.dev/api/public/dossier/b4677ca1-d91c-5fc5-ba5d-40a91e323092
identifier: sec:0001022936
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# SANDERS CHARLES A

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001022936`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/b4677ca1-d91c-5fc5-ba5d-40a91e323092  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/b4677ca1-d91c-5fc5-ba5d-40a91e323092  

## Ownership & control

### Holdings / subsidiaries

- **BIOPURE CORP** (director) — https://whiteintel.dev/entity/c89caf04-4f14-569a-86ac-886904a3c739
- **ICAGEN INC** (director) — https://whiteintel.dev/entity/8bb5d6ec-5781-5fdd-9c3f-f7fb56b4f2c3
- **BIOCRYST PHARMACEUTICALS INC** (director) — https://whiteintel.dev/entity/4c2abb17-afd7-5282-930a-5a120a05fb83
- **LIPOSCIENCE INC** (director) — https://whiteintel.dev/entity/6d0233df-38a6-5643-a1cd-3941687b8b5a
- **ALBIREO PHARMA, INC.** (director) — https://whiteintel.dev/entity/fbac61b4-9e56-5994-8b1c-ac13b57a3440
- **CEPHALON INC** (director) — https://whiteintel.dev/entity/bacde539-e5d5-555a-93c4-6b525188a740
- **VERTEX PHARMACEUTICALS INC / MA** (director) — https://whiteintel.dev/entity/71acdf6c-489a-5611-a135-def38df30ab8
- **GENENTECH INC** (director) — https://whiteintel.dev/entity/d3df1b86-e293-5196-a0a1-d9bd5f7f0a88
- **FISHER SCIENTIFIC INTERNATIONAL INC** (director) — https://whiteintel.dev/entity/639a61c3-deff-51f4-9be7-0fe05232cfd8

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **SANDERS CHARLES A**. Human view: https://whiteintel.dev/entity/b4677ca1-d91c-5fc5-ba5d-40a91e323092 · Structured JSON: https://whiteintel.dev/api/public/dossier/b4677ca1-d91c-5fc5-ba5d-40a91e323092._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._